SIMONE GHISLANDI

Laurea in Economics, Bocconi University. Mphil and DPhil, Department of Economics, University of Oxford

Assistant Professor, Department of Policy Analysis and Public Management

Health Economics: economics and epidemiology, demand for pharmaceuticals and health treatments. Industry and Health economics: empirical and theoretical analysis of regulation in pharmaceuticals. Health Policy: analysis of health systems and pharmaceutical policies.

Effects of the economic crisis on smoking prevalence and number of smokers in the USA (with Raya Muttarak and Silvano Gallus), Tobacco Control, forthcoming; The impact of generic reference price in Italy, a decade on (with Patrizio Armeni and Claudio Jommi) European Journal of Health Economics, Forthcoming; Assessing the outcomes of implantable cardioverter defibrillators in a real world setting: what results from hospital records data?  (with Aleksandra Torbica and Giuseppe Boriani), BMC Health Services Research, 2013; 13:100. Competition and the reference price for pharmaceuticals, Journal of Health Economics, 2011; 30(6): 1137-1149; Smoking in italy 2008-2009. A raise in prevalence related to the economic crisis? (with Silvano Gallus et al), Preventive Medicine, 2011; 52(2): 97-98; Effects of Reference Pricing in pharmaceutical markets: a review (with Matteo galizzi and Marisa Miraldo), PharmacoEconomics, 2011; 29(1): 17-33;  Should we really worry about “launch delays” in OECD countries? (with Livio Garattini), European Journal of Health Economics, 2007; 8(1): 1-3; Off-patent drugs in Italy: a short-sighted view? (with Livio Garattni), European Journal of Health Economics, 2006; 7(1): 79-83; Italian pharmaceutical policy: toward a structural change? (with Livio Garattini e Iva Krulikova), Health Policy, 2005; 72(3): 53-63; Is EQ-5D a valid measure of HRQoL in patients with movement disorders? (with Giovanni Apolone , Livio Garattini e Ivo Ghislandi), European Journal of Health